Sovremennye mukolitiki v lechenii ORVI i grippa [Modern mucolytics in the treatment of acute viral diseases and influenza].

Respiratory diseases are the most common among adults and children. To date, according to WHO, between 27.3 and 41.2 million people suffer from influenza and other viral infections in the Russian Federation, while in the world – up to 1 billion cases, of which 3 to 5 million are severe. Acute viral respiratory infections’ annual incidence among children is 20-30%. To diagnose acute respiratory viral infections, it is necessary to have at least one of the clinical manifestations characteristic of respiratory diseases. Diagnostic studies conducted on an outpatient basis make it possible to accurately diagnose and prescribe medication. And also provide general recommendations. The need for timely treatment of respiratory diseases is explained by the high frequency of complications that lead to fatal consequences. The article tells about the main support points for general practitioners and pulmonologists who face these diseases.

1. Samsygina GA. Cough in children: clinical guidelines. Moscow : GEOTAR-Media, 2017. p. 176. (in Russ.).

2. Shamsheva OV. Flu and ARVI in children. Moscow : GEOTAR-Media, 2017. p. 112. (in Russ.).

3. Bulgakova, VA. Acute respiratory infections in children: problems and possibilities of therapy. Pediatrics: supplement to the journal Consilium Medicum. 2016;3:37–42. (in Russ.).

4. Acute respiratory viral infection (ARVI) in children: 2018: clinical guidelines. Moscow, 2018. p. 33. (in Russ.).

5. Molochny VP, Protasenya II, Gladkikh RA. Acute respiratory viral infections in children: guidelines. Khabarovsk, 2018. p. 36. (in Russ.).

6. Baranov AA, Lobzin YuV, Namazova-Baranova LS. Acute respiratory viral infection in children: modern approaches to diagnosis and treatment. Practical Pharmacology. 2017;2:101–108. (in Russ.).

7. Girina AA, Zaplatnikov AL, Burtseva EI. Treatment of acute respiratory viral infections and influenza in children the principle of minimal sufficiency. Medical Council. 2016;7:44–48. (in Russ.).

8. Shatalina, S.I., Aksenova M.B., Khlevchuk T.V. Cough in children. How and what to treat? Farmateka. 2019;1:77–83. (in Russ.).

9. Shatalina SI, Kolosova NG, Aksenova MB, Khlevchuk TV. Mucolytics in the treatment of cough in children: the versatility of properties. Farmateka. 2018;8:84–89. (in Russ.).

10. Kosenko IM. Recurrent respiratory infections in children: modern approaches to rational pharmacotherapy. Pediatrics: supplement to the journal Consilium Medicum. 2018;1:51–56. (in Russ.).

11. Nikitina LV. Treatment of ARVI in children. Attending physician. 2018;6:44–48. (in Russ.).

12. Ruzhentsova TA, Ploskireva AA, Aleshina NI. Possibilities of increasing the effectiveness of therapy for acute respiratory viral infections of various etiologies in children. Infectious diseases. 2019;2:46–52. (in Russ.).

13. Ershova IB, Osipova TF. Use of inhalations with herbal preparations for complications of acute respiratory viral diseases. Actual infectology. 2017;2:112–118. (in Russ.).